Advertisement

Topics

Chi-Med to Announce 2017 Half-Year Financial Results

05:20 EDT 29 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) will be announcing its interim results for the six months ended June 30, 2017 on Monday, July 31, 2017 at 7:00 am British Summer Time (BST). An analyst ...

Other Sources for this Article

Chi-Med
Investor Enquiries

Christian Hogg, CEO
+852 2121 8200
or
U.K. & International Media Enquiries
Citigate Dewe Rogerson

Anthony Carlisle
+44 7973 611 888 (Mobile)
anthony.carlisle@cdrconsultancy.co.uk
or
U.S. Based Media Enquiries
BMC Communications

Brad Miles
+1 (917) 570 7340 (Mobile)
bmiles@bmccommunications.com
or
Susan Duffy
+1 (917) 499 8887 (Mobile)
sduffy@bmccommunications.com
or
Investor Relations
Matt Beck, The Trout Group
+1 (917) 415 1750 (Mobile)
mbeck@troutgroup.com
or
David Dible, Citigate Dewe Rogerson
+44 7967 566 919 (Mobile)
david.dible@citigatedr.co.uk
or
Panmure Gordon (UK) Limited
Richard Gray / Andrew Potts
+44 (20) 7886 2500

NEXT ARTICLE

More From BioPortfolio on "Chi-Med to Announce 2017 Half-Year Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...